{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:08:43Z","timestamp":1780423723083,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.idc.2020.06.011","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T10:25:58Z","timestamp":1596882358000},"page":"559-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons"],"prefix":"10.1016","volume":"34","author":[{"given":"Nikhil","family":"Seval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysse","family":"Wurcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig G.","family":"Gunderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Grimshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.idc.2020.06.011_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory HCV Collaborators","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.idc.2020.06.011_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/add.14393","article-title":"Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs","volume":"114","author":"Grebely","year":"2019","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.idc.2020.06.011_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2017","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.idc.2020.06.011_bib4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis","volume":"58","author":"Larney","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.idc.2020.06.011_bib5","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ (Clin Res Ed)"},{"issue":"2","key":"10.1016\/j.idc.2020.06.011_bib6","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.idc.2020.06.011_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/QAI.0000000000001634","article-title":"Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial","volume":"78","author":"Springer","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr (1999)"},{"issue":"1","key":"10.1016\/j.idc.2020.06.011_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/QAI.0000000000001759","article-title":"Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial","volume":"79","author":"Springer","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr (1999)"},{"issue":"5","key":"10.1016\/j.idc.2020.06.011_bib9","doi-asserted-by":"crossref","first-page":"e38335","DOI":"10.1371\/journal.pone.0038335","article-title":"Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners","volume":"7","author":"Springer","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.idc.2020.06.011_bib10","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/cid\/ciz693","article-title":"Low Hepatitis C Reinfection Following Direct-Acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy","volume":"70","author":"Akiyama","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.06.011_bib11","article-title":"Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs","volume":"ciaa105","author":"Rosenthal","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.06.011_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis","volume":"113","author":"Platt","year":"2018","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.idc.2020.06.011_bib13","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.idc.2020.06.011_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/JCM.01229-07","article-title":"Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates","volume":"46","author":"Page-Shafer","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2020.06.011_bib15","author":"Wells"},{"key":"10.1016\/j.idc.2020.06.011_bib16","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clin Res Ed)"},{"issue":"3","key":"10.1016\/j.idc.2020.06.011_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"7414","key":"10.1016\/j.idc.2020.06.011_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clin Res Ed)"},{"issue":"9","key":"10.1016\/j.idc.2020.06.011_bib19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jvh.12701","article-title":"Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study","volume":"24","author":"Cunningham","year":"2017","journal-title":"J\u00a0Viral Hepat"},{"issue":"2","key":"10.1016\/j.idc.2020.06.011_bib20","doi-asserted-by":"crossref","first-page":"e90560","DOI":"10.1371\/journal.pone.0090560","article-title":"Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period","volume":"9","author":"Marco","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2020.06.011_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2013.03.008","article-title":"Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C","volume":"59","author":"Marco","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.idc.2020.06.011_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0376-8716(03)00187-X","article-title":"A\u00a0randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system","volume":"72","author":"Dolan","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.idc.2020.06.011_bib23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/add.12107","article-title":"Low incidence of hepatitis C virus among prisoners in Scotland","volume":"108","author":"Taylor","year":"2013","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.idc.2020.06.011_bib24","doi-asserted-by":"crossref","first-page":"e0220297","DOI":"10.1371\/journal.pone.0220297","article-title":"Incidence, prevalence and risk factors for hepatitis C in Danish prisons","volume":"14","author":"S\u00f8holm","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2020.06.011_bib25","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/1471-2458-10-633","article-title":"Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort","volume":"10","author":"Teutsch","year":"2010","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.idc.2020.06.011_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10654-009-9421-0","article-title":"Incidence and risk for acute hepatitis C infection during imprisonment in Australia","volume":"25","author":"Dolan","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"10.1016\/j.idc.2020.06.011_bib27","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/add.12643","article-title":"A\u00a0prospective study of hepatitis C incidence in Australian prisoners","volume":"109","author":"Luciani","year":"2014","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.idc.2020.06.011_bib28","doi-asserted-by":"crossref","first-page":"e104515","DOI":"10.1371\/journal.pone.0104515","article-title":"Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions","volume":"9","author":"Palmateer","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.idc.2020.06.011_bib29","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41395-018-0157-x","article-title":"Microenvironment eradication of hepatitis C: a novel treatment paradigm","volume":"113","author":"Cuadrado","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.idc.2020.06.011_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7326\/M15-0617","article-title":"Prevention of hepatitis C by screening and treatment in U.S. prisons","volume":"164","author":"He","year":"2016","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.idc.2020.06.011_bib31","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1473-3099(18)30469-9","article-title":"Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis","volume":"18","author":"Stone","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.idc.2020.06.011_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.idc.2020.06.011_bib33","unstructured":"Pesce vs. Coppinger, 355 F. Supp. 3d 35 (D. Mass. 2018)."}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552020300453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552020300453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:17:24Z","timestamp":1760195844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552020300453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0891552020300453"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2020.06.011","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2020.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}